Cambridge, Massachusetts
United States
38
2020-01-02
37
2021-07-13
These are the the leading inventors for applications assigned to DICERNA PHARMACEUTICALS, INC.:
DICERNA PHARMACEUTICALS, INC. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#2 | 2019-12-26 ✅ Patent 10,844,381 granted on 2020-11-24Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
#3 | 2019-10-24 ✅ Patent 10,738,311 granted on 2020-08-11Therapeutic inhibition of lactate dehydrogenase and agents therefor
#4 | 2019-07-18 ✅ Patent 10,954,517 granted on 2021-03-23Methods and compositions for the specific inhibition of complement component 5(C5) by double-stranded RNA
#5 | 2019-07-11 ✅ Patent 10,487,330 granted on 2019-11-26Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#6 | 2019-06-27 ✅ Patent 10,465,195 granted on 2019-11-05Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#7 | 2019-05-23 ✅ Patent 11,351,265 granted on 2022-06-07Process for formulating an anionic agent
#8 | 2019-05-16 ✅ Patent 10,676,742 granted on 2020-06-09Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA
#9 | 2019-01-03 ✅ Patent 10,612,023 granted on 2020-04-07Methods and compositions for the specific inhibition of β-catenin by double-stranded RNA
#10 | 2019-01-03 ✅ Patent 10,675,295 granted on 2020-06-09Compositions and methods for inhibiting HMGB1 expression
#11 | 2018-10-11 ✅ Patent 10,435,692 granted on 2019-10-08Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#12 | 2017-10-26 ✅ Patent 9,828,606 granted on 2017-11-28Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#13 | 2017-10-26 ✅ Patent 10,351,854 granted on 2019-07-16Therapeutic inhibition of lactate dehydrogenase and agents therefor
#14 | 2017-05-18 ✅ Patent 10,144,725 granted on 2018-12-04Amine cationic lipids and uses thereof
#15 | 2017-05-11 ✅ Patent 10,370,655 granted on 2019-08-06Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
#16 | 2017-04-13RNAi PHARMACEUTICAL COMPOSITION FOR SUPPRESSING EXPRESSION OF CKAP5 GENE
#17 | 2016-10-20 ✅ Patent 10,150,965 granted on 2018-12-11Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA
#18 | 2016-08-18 ✅ Patent 10,036,017 granted on 2018-07-31Methods and compositions for the specific inhibition of complement component 5(C5) by double-stranded RNA
#19 | 2016-06-30 ✅ Patent 10,072,263 granted on 2018-09-11Methods and compositions for the specific inhibition of beta-catenin by double-stranded RNA
#20 | 2016-06-23 ✅ Patent 10,011,834 granted on 2018-07-03Methods and compositions for the specific inhibition of HIF-1α by double-stranded RNA
#21 | 2016-03-24 ✅ Patent 9,790,498 granted on 2017-10-17Phase changing formulations of nucleic acid payloads
#22 | 2016-02-25 ✅ Patent 9,428,752 granted on 2016-08-30Methods and compositions for the specific inhibition of beta-catenin by double-stranded RNA
#23 | 2015-12-31 ✅ Patent 10,137,201 granted on 2018-11-27Process for formulating an anionic agent
#24 | 2015-11-05 ✅ Patent 9,850,486 granted on 2017-12-26Methods and compositions for the specific inhibition of CKAP5 by double-stranded RNA
#25 | 2015-08-27 ✅ Patent 9,562,228 granted on 2017-02-07Methods and compositions for the specific inhibition of MYC by double-stranded RNA
#26 | 2015-07-16 ✅ Patent 9,732,347 granted on 2017-08-15Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA
#27 | 2015-07-02 ✅ Patent 9,701,966 granted on 2017-07-11Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#28 | 2015-03-05 ✅ Patent 9,708,605 granted on 2017-07-18Methods and compositions for the specific inhibition of MCL1 by double-stranded RNA
#29 | 2015-02-26 ✅ Patent 9,809,819 granted on 2017-11-07Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA
#30 | 2015-01-08 ✅ Patent 9,458,457 granted on 2016-10-04Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
#31 | 2014-12-18 ✅ Patent 9,549,983 granted on 2017-01-24Amine cationic lipids and uses thereof
#32 | 2014-11-27 ✅ Patent 10,131,912 granted on 2018-11-20Extended dicer substrate agents and methods for the specific inhibition of gene expression
#33 | 2014-10-23 ✅ Patent 9,670,488 granted on 2017-06-06Methods and compositions for the specific inhibition of met by double stranded RNA
#34 | 2014-09-25 ✅ Patent 9,243,244 granted on 2016-01-26Methods and compositions for the specific inhibition of beta-catenin by double stranded RNA
#35 | 2014-06-26 ✅ Patent 9,217,146 granted on 2015-12-22Phase changing formulations of nucleic acid payloads
#36 | 2014-04-17 ✅ Patent 9,365,850 granted on 2016-06-14Methods and compositions for the specific inhibition of MYC by double-stranded RNA
#37 | 2013-11-14 ✅ Patent 9,206,420 granted on 2015-12-08Methods and compositions for the specific inhibition of HIF-1α by double-stranded RNA
#38 | 2013-08-29 ✅ Patent 9,320,798 granted on 2016-04-26Lipid delivery formulations
Also check out Dicerna Pharmaceuticals, Inc.'s (Cambridge, United States) applicant profile with 27 patent applications submitted.
97781 ⎘